Dyne Therapeutics, Inc.DYNNASDAQ
Loading
Operating Cash Flow Growth Recovery in ProgressRecovering
Percentile Rank57
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
-37.91%
↓ 39% vs avg
Percentile
P57
Within normal range
Streak
1 yr
Consecutive growthRecovering
Average
-27.36%
Historical baseline
PeriodValue
2025-37.91%
2024-55.38%
2023-22.46%
2022-28.51%
2021-157.08%
2020-293.00%
2019-184.20%
2018-100.71%
2017-13.46%
2016619.15%